Hemoglobin A1c change from baseline -0.33 -0.17e -0.19 F=.43 p=.65 at 12 months(mean) Systolic blood pressure change from 3.34 0.76e -4.92 F=3.84 p=.02 baseline to 12 months(mean scale) Wakefield, 2012 Self-efficacy scores from baseline at 6 8.1 8.1 7.7 p=.09 months Self-efficacy scores from baseline at 12 8.3 8.3 7.8 p=.19 months Medication-taking adherence from 99.6 99.8 99.6 p=.79 baseline at 6 months Medication-taking adherence from 98.9 99.7 100 f p=.20 baseline at 12 months aArticle reported intervention effects on 2 patients. Statistical not appropriate. bNo control group in this study. Values under represent 10 month follow-up and those under represent 20 month follow-up “Control” “Intervention” NR= not reported; NA=not applicable; PHQ-9= Patient Health Questionnaire- 9 items; ADL= Activities of Daily Living; IADL= Instrumental Activities of Daily Living; NRS= Numeric Ration System; FACLS= Face, Legs, Activity, Cry, Consolability Scale; HDRS= Hamilton Depression Rating Scale-24 items; SF-12= Short Form-12 items; SDS= Sheehan Disability Scale; AOR= Adjusted odds ratio; CE=Coefficient estimate c Control represent baseline data for the intervention group and the intervention group represents outcomes at 12 months. d Control represent patients in Switzerland and intervention group represents patients in the U.S.
Hemoglobin A1c change from baseline at 12 months(mean) -0.33 -0.17e -0.19 F=.43 p=.65 Systolic blood pressure change from baseline to 12 months(mean scale) 3.34 0.76e -4.92 F=3.84 p=.02 Wakefield, 2012 Self-efficacy scores from baseline at 6 months 8.1 8.1 7.7 p=.09 Self-efficacy scores from baseline at 12 months 8.3 8.3 7.8 p=.19 Medication-taking adherence from baseline at 6 months 99.6 99.8 99.6 p=.79 Medication-taking adherence from baseline at 12 months 98.9 99.7 100 f p=.20 aArticle reported intervention effects on 2 patients. Statistical not appropriate. bNo control group in this study. Values under “Control” represent 10 month follow-up and those under “Intervention” represent 20 month follow-up NR= not reported; NA=not applicable; PHQ-9= Patient Health Questionnaire- 9 items; ADL= Activities of Daily Living; IADL= Instrumental Activities of Daily Living; NRS= Numeric Ration System; FACLS= Face, Legs, Activity, Cry, Consolability Scale; HDRS= Hamilton Depression Rating Scale-24 items; SF-12= Short Form-12 items; SDS= Sheehan Disability Scale; AOR= Adjusted odds ratio; CE=Coefficient estimate c Control represent baseline data for the intervention group and the intervention group represents outcomes at 12 months. d Control represent patients in Switzerland and intervention group represents patients in the U.S.